Biotalys NV

Biotalys NV

BTLS · BR · Basic Materials / Agricultural Inputs

1.85EUR-0.05 (-2.84%)

Price History

Full chart

Market Stats

Previous Close1.90
Open1.92
Day Range1.85 – 1.93
52-Week Range1.56 – 5.28
Volume4.28K
Market Cap86.80M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.43
Dividend Yield0.00%
Beta1.37
50-Day Avg2.37
200-Day Avg2.74

About

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and other fungi in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Ghent, Belgium.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEODr. Carlo Boutton
  • Employees37
  • HeadquartersBuchtenstraat 11, Ghent, Belgium, 9051, Belgium
  • Websitehttps://biotalys.com

Leadership

  • Dr. Carlo BouttonCEO & Chief Scientific Officer
  • Mr. Luc Van FraeyenhovenChief Financial Officer
  • Toon MusschootHead of Investor Relations & Communication

Financials

Income Statement

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0000000
Operating Income-9.24M-13.28M-18.08M-22.53M-20.89M-13.49M-15.84M
EBITDA-8.66M-13.01M-16.77M-20.95M-19.51M-12.35M-13.86M
Net Income-7.67M-10.75M-16.93M-22.73M-20.51M-13.19M-15.76M
R&D7.85M11.49M13.88M18.81M16.66M11.01M13.27M
Interest Expense774.00K86.00K246.00K247.00K161.00K157.00K108.00K

Balance Sheet

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10.88M27.51M36.26M70.27M49.52M36.58M36.75M19.73M
Total Liabilities8.66M6.44M10.61M11.36M11.40M11.01M9.14M7.63M
Total Equity2.22M21.07M25.65M58.91M38.11M25.57M27.61M12.10M
Cash7.77M23.36M23.10M56.11M34.10M21.57M22.64M8.04M
Total Debt4.80M1.19M5.22M7.22M6.50M6.07M4.85M3.78M
Net Debt-2.97M-22.16M-17.88M-48.88M-27.59M-15.50M-22.64M-4.26M

Cash Flow

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.22M-9.53M-16.75M-20.09M-18.28M-12.65M-13.68M
Investing Cash Flow-641.00K-6.02M-1.32M-684.00K233.00K577.00K108.00K
Financing Cash Flow24.45M15.29M51.08M-1.24M5.53M13.14M-1.03M
Capital Expenditure645.00K3.93M1.33M707.00K455.00K138.00K182.00K
Free Cash Flow-8.87M-13.46M-18.09M-20.80M-18.74M-12.79M-13.86M
FCF to OCF107.84%141.24%107.95%103.52%102.49%101.09%101.33%

Earnings

Report DateJun 23, 2021Dec 8, 2021Mar 11, 2022Aug 19, 2022Feb 28, 2023Mar 18, 2025Sep 18, 2025Mar 18, 2027
EPS Estimate0.000.000.000.000.000.00--
EPS Actual-0.36-0.11-0.55-0.32-0.74-0.20-0.22-
Surprise--------
Timing-Pre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap86.80M
Enterprise Value79.63M
Trailing P/E0.00
Forward P/E0.00
Price / Sales326.31
Price / Book6.04
EPS-0.43
Book Value0.381
Revenue (TTM)266.00K
Gross Profit (TTM)266.00K
EBITDA-13.79M
Profit Margin0.00%
Operating Margin-437.51%
Return on Equity-96.43%
Return on Assets-36.14%
Shares Outstanding45.44M
Shares Float25.63M
Beta1.37
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%